Nanoscope Therapeutics submitted the first modules of a biologics license application for MCO-010, an investigational gene ...

Nanoscope’s BLA has been granted rolling review by the FDA, with the first modules already submitted. The completion of the ...

Nanoscope Therapeutics begins rolling submission of BLA to US FDA for gene-agnostic therapy, MCO-010 to treat retinitis pigmentosa: Dallas, Texas Wednesday, July 16, 2025, 14:30 H ...

Scientists at the Jules Stein Eye Institute at the David Geffen School of Medicine at UCLA have discovered that certain ...

New research shows that retinal neurons can rewire to preserve vision in retinitis pigmentosa, a genetic disease causing blindness.

Female sex hormones can significantly enhance the progression of the rare neurodegenerative eye disease retinitis pigmentosa (RP), according to a preclinical study by researchers at UT Southwestern ...

Retinitis pigmentosa RP is a collection of inherited eye diseases that cause progressive vision loss It causes degeneration ...

UCLA scientists found that in early retinitis pigmentosa, rod bipolar cells in mice rewire to connect with cones, preserving ...

In experiments in mice, US researchers found that retinal cells were capable of rewiring once vision starts to deteriorate ...

If approved, MCO-010 would be the first treatment to restore vision in legally blind RP patients without needing genetic ...

Scientists at the Jules Stein Eye Institute at the David Geffen School of Medicine at UCLA have discovered that certain retinal cells can rewire ...

A girl from Stevenage who has an incurable eye disease has undergone a pioneering gene therapy which has allowed her to see in the dark and ...